Dihydrotestosterone

  • 2 independent labs in 1 country
  • Funder: National Research Foundation of Korea
  • Animals2

Outcomes

5

VCAM1

upin mice1

1 study
  1. Dihydrotestosterone increases VCAM1 in mice.

    “re-induced VCAM1 expression in YFP+/Pax7-/low/VCAM1- cells”

    Animalsin YFP+/Pax7-/low/VCAM1- cellsskeletal muscle

    Rejuvenation-Responsive and Senolytic-Sensitive Muscle Stem Cells Unveiled by CD200 and CD63 in Geriatric Muscle

    eLife25 Mar 2026Preprint

More on VCAM1

Muscle regeneration

upin mice1

1 study
  1. Dihydrotestosterone improves muscle regeneration in mice.

    “DHT restored regenerative function in aged mice”

    Animalsskeletal muscle

    Rejuvenation-Responsive and Senolytic-Sensitive Muscle Stem Cells Unveiled by CD200 and CD63 in Geriatric Muscle

    eLife25 Mar 2026Preprint

Inflammation

downin mice1

1 study
  1. Dihydrotestosterone inhibits inflammation in mice.

    “DHT treatment rejuvenates HGPS hearts, upregulates pathways linked to heart function and downregulates inflammatory responses”

    Animalsin HGPS miceheart

    DHT ameliorates cardiac aging in progeroid mice by XRCC4-mediated genome stabilization

    Mechanisms of ageing and development3 Dec 2025

More on Inflammation

Cardiac function

upin mice1

1 study
  1. Dihydrotestosterone improves cardiac function in mice.

    “DHT administration reduces DNA damage accumulation and promotes structural and functional recovery in HGPS hearts.”

    Animalsin HGPS miceheart

    DHT ameliorates cardiac aging in progeroid mice by XRCC4-mediated genome stabilization

    Mechanisms of ageing and development3 Dec 2025

DNA damage accumulation

downin mice1

1 study
  1. Dihydrotestosterone decreases DNA damage accumulation in mice.

    “DHT administration reduces DNA damage accumulation and promotes structural and functional recovery in HGPS hearts.”

    Animalsin HGPS miceheart

    DHT ameliorates cardiac aging in progeroid mice by XRCC4-mediated genome stabilization

    Mechanisms of ageing and development3 Dec 2025

More on DNA damage accumulation

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 1Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 16 in 12 months
JAMA Otolaryngology-- Head & Neck Surgery

5-ARI use is tied to lower laryngeal cancer risk in men

In a Swedish cohort, 5-ARI users had a 17% lower risk of laryngeal or hypopharyngeal squamous cell carcinoma than nonusers (adjusted hazard ratio, 0.83).In a Swedish cohort, 5-ARI users had a 17% lower risk of laryngeal or hypopharyngeal squamous cell carcinoma than nonusers (adjusted hazard ratio, 0.83).

Cohort study in peoplePopulations